Low‐dose aspirin use and colorectal cancer survival in 32,195 patients—A national cohort study

Autor: Mehrnoosh Shahrivar, Caroline E. Weibull, Karin Ekström Smedby, Bengt Glimelius, Ingvar Syk, Peter Matthiessen, Caroline Nordenvall, Anna Martling

Publikováno v: Cancer Medicine, Vol 12, Iss 1, Pp 315-324 (2023)

Abstract Background Results from previous studies indicate that use of aspirin may improve colorectal cancer (CRC) survival. The aim of this study was to assess whether use of aspirin influences overall survival or CRC‐specific survival in an unsel

Externí odkaz: https://doaj.org/article/55d35f0ba0e24b62b6635101111c46e7

Preoperative short-course radiation therapy with PROtons compared to photons in high-risk RECTal cancer (PRORECT): Initial dosimetric experience

Autor: Cristiana Pedone, Bruno Sorcini, Caroline Staff, Johanna Färlin, Tone Fokstuen, Jan-Erik Frödin, Per J. Nilsson, Anna Martling, Alexander Valdman

Publikováno v: Clinical and Translational Radiation Oncology, Vol 39, Iss , Pp 100562- (2023)

Background and purpose: Neoadjuvant short-course radiotherapy (SCRT) followed by full-dose systemic chemotherapy is an established treatment modality in locally advanced rectal cancer (LARC). Until recently, SCRT has been exclusively delivered with p

Externí odkaz: https://doaj.org/article/a54c8fc5ae1b4c35ba36486ef441626d

Supplementary Figure 1 from Work Loss Duration and Predictors Following Rectal Cancer Treatment among Patients with and without Prediagnostic Work Loss

Autor: Karin E. Smedby, Sandra Eloranta, Anna Martling, Sara Ekberg, Martin Neovius, Ingrid Glimelius, Lingjing Chen

Supplementary Figure S1. Annual distribution of patients by extent of annual work loss (0, 1-180, 181-359 and >360 days) from two years before to five years after rectal cancer diagnosis for relapse-free patients without pre-diagnostic work loss befo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2eaebd3c17604e12e89b8e6bfca8aa75
https://doi.org/10.1158/1055-9965.22438225.v1

Data from Work Loss Duration and Predictors Following Rectal Cancer Treatment among Patients with and without Prediagnostic Work Loss

Autor: Karin E. Smedby, Sandra Eloranta, Anna Martling, Sara Ekberg, Martin Neovius, Ingrid Glimelius, Lingjing Chen

Background: The number of working-age rectal cancer survivors is increasing due to early detection and improved treatment. However, work loss duration and predictors among them have not been studied thoroughly.Methods: We identified 3,438 patients wi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::076c50144357c9ffd037862872d4ba20
https://doi.org/10.1158/1055-9965.c.6516271

High resection rates of colorectal liver metastases after standardized follow-up and multimodal management: an outcome study within the COLOFOL trial

Autor: Peter Scherman, Pernilla Hansdotter, Erik Holmberg, Frank Viborg Mortensen, Sune H. Petersen, Magnus Rizell, Peter Naredi, Ingvar Syk, Peer Wille-Jørgensen, Erzsébet Horváth-Puhó, Søren Laurberg, Lars Påhlman, Andrew Renehan, Kenneth Smedh, Henrik Christensen, Jesper Dan Nielsen, Per Jess, Allan Gorm Pedersen, Mogens Rørbæk Madsen, Per Vadgaard Andersen, Erling Østergaard, Pernilla Hansdotter Andersson, Jonas Bengtsson, Mats Bragmark, Pamela Buchwald, Monika Egenvall, Parastau Farahnak, Joakim Folkesson, Michael Goldinger, Rolf Heuman, Kenneth Lindberg, Anna Martling, Pia Näsvall, Johan Ottosson, Birger Sandzén, Carlos Barberousse

Publikováno v: Scherman, P, Hansdotter, P, Holmberg, E, Viborg Mortensen, F, Petersen, S H, Rizell, M, Naredi, P, Syk, I & COLOFOL Study Group 2023, ' High resection rates of colorectal liver metastases after standardized follow-up and multimodal management : an outcome study within the COLOFOL trial ', HPB, vol. 25, no. 7, pp. 766-774 . https://doi.org/10.1016/j.hpb.2023.03.003
Scherman, P, Hansdotter, P, Holmberg, E, Viborg Mortensen, F, Petersen, S H, Rizell, M, Naredi, P, Syk, I, COLOFOL study group & Nielsen, J D 2023, ' High resection rates of colorectal liver metastases after standardized follow-up and multimodal management : an outcome study within the COLOFOL trial ', H P B . https://doi.org/10.1016/j.hpb.2023.03.003
Scherman, P, Hansdotter, P, Holmberg, E, Viborg Mortensen, F, Petersen, S H, Rizell, M, Naredi, P, Syk, I, COLOFOL study group & Nielsen, J D 2023, ' High resection rates of colorectal liver metastases after standardized follow-up and multimodal management : an outcome study within the COLOFOL trial ', H P B, vol. 25, no. 7, pp. 766-774 . https://doi.org/10.1016/j.hpb.2023.03.003

Background: Outcome after colorectal liver metastases (CRLM) resection has improved over time, despite increased resection rates. Hence, it's crucial to identify all patients possible to treat with curative intent. The objectives of this study were t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ec158f1f47ca75be9290b4755f5df74
https://doi.org/10.1016/j.hpb.2023.03.003